Our data demonstrated that bilateral injecting the rAAV2/6M-DIO-taCasp3 virus into CD11c-cre mice cut down more than half of CD11c+ microglia 21 days after tMCAO, which allowed us to verify the functional features of CD11c+ microglia during the late phase of stroke. This evidence concerns the gene ITGAX and stroke disorder.